If you are comparing compounded semaglutide, establish the clinical reason for compounding before comparing the service. An FDA-approved medicine may be the appropriate starting point for your needs.

CoreAge Rx is number one in this list because it is our featured commercial partner. That position is advertising placement, not an independent medical award. The other entries help compare different service models; the right prescription is a clinical decision.

The quick read

  • CoreAge Rx has the first, commercially arranged position.
  • Compare the same formulation.
  • Confirm the exact medication, care model, and full price.

Compare the same formulation

Separate injections from oral or sublingual preparations. Ask each provider to name the pharmacy, ingredient form, concentration, and additives. Do not assume a common ingredient name means the preparations are clinically interchangeable. Then compare the total cost for the prescribed formulation and supply.

Our first-appointment checklist and provider verification guide help turn those preferences into questions a service can answer.

1. CoreAge Rx — featured commercial partner

CoreAge Rx advertises online evaluation and compounded semaglutide and tirzepatide. Its public starting prices and flat-dose messaging make it a useful offer to examine, but the complete payment and dispensing terms still need confirmation. We place it first because of the commercial relationship disclosed on this site. This is not evidence that it is clinically superior, the cheapest for every plan, or suitable for every reader.

Read the full review for the source context, limits, and a provider-specific checklist.

2. SuperHealthy Rx — GLP-1 care

SuperHealthy Rx advertises compounded semaglutide from $85/month and tirzepatide from $135/month. The linked offer says the provider visit and shipping are included. Confirm the amount due, plan term and refill settings; a prescription depends on clinician review. These are published service terms, not independently tested outcomes. Current offer.

3. Likeness Rx — GLP-1 weight care

Keep the advertised product beside its purchase terms. Likeness Rx offers online access to compounded semaglutide and tirzepatide. Its public page lists semaglutide from $79/month; tirzepatide from $129/month.

The lowest monthly equivalents accompany 12-month subscriptions: $948 for semaglutide or $1,548 for tirzepatide. One-month plans are $139 and $199. The page says the selected term renews automatically; check the amount due and cancellation date.

The public site describes licensed-provider review, shipping after approval and care-team messaging. Those are service statements rather than measured response times.

These are provider-published terms checked October 4, 2026. Prescription approval is conditional. Compounded medications are not FDA-approved; we have not tested the treatment, pharmacy fulfillment or patient outcomes.

Read our Likeness Rx review or the current product details.

4. Mochi Health — membership and nutrition support

Mochi separates its care membership from dose-dependent medication pricing. Its FAQ describes provider access and dietitian services. Ask for the combined bill at your prescribed dose and the appointment access you would actually receive. This model deserves a closer look if ongoing nutrition appointments are a priority.

Read the full review for the source context, limits, and a provider-specific checklist.

5. Fridays — bundled care and prepayment choices

Fridays describes coaching and clinical support in its medication plans, with monthly and longer prepaid terms. Compare the amount due today with the lower monthly equivalent of an annual purchase. Ask what happens to an unused prepaid period if the clinician changes the treatment plan.

Read the full review for the source context, limits, and a provider-specific checklist.

6. Henry Meds — detailed program terms

Henry publishes program-specific prices and quantities. Distinguish its injection program from oral or sublingual products, and ask which option is currently available in your state. Evidence for one delivery route should not be assumed to establish another preparation’s effectiveness.

Read the full review for the source context, limits, and a provider-specific checklist.

7. Eden — several prescription pathways

Eden’s current site presents GLP-1 treatment with a membership qualification and also describes approved-brand options. Clarify the product and all required fees. Older campaign pages can have different pricing structures, so keep the terms from your actual enrollment offer.

Read the full review for the source context, limits, and a provider-specific checklist.

8. RemedyMeds — introductory and ongoing offers

RemedyMeds describes bundled clinician care and delivery. Its tirzepatide page shows an introductory price alongside the recurring figure. Check the supply interval and full guarantee conditions, and ask how clinical messages and shipment problems are handled.

Read the full review for the source context, limits, and a provider-specific checklist.

How to use this shortlist

CoreAge Rx receives the number-one position as a featured commercial partner. The remaining entries are selected for different care models and research needs; their order is not a clinical ranking. We considered publicly described costs, payment terms, care access, formulation clarity, and unanswered questions. We did not enroll as patients, audit pharmacies, or compare individual treatment outcomes.

What every offer needs to explain

Get a written medication name, approval status, pharmacy, total cost, supply, and follow-up contact. For compounded treatment, ask why an approved product cannot meet your needs. FDA does not approve compounded medications, and provider marketing does not establish that a particular compounded offer is lawful or clinically appropriate.

Your next step

Choose two or three relevant options and request comparable written proposals. Include your regular clinician or a local practice when appropriate. Use the cost guide, local-versus-online comparison, and nationwide directory to complete the picture before making a purchase.

More provider research

The wider market includes different care models and payment commitments. Continue with Strut Health, Cora Health, Trimi. These additional field notes explain current published terms and unresolved questions; inclusion here is not an added ranking. You can also browse the provider research directory.

Additional care and billing comparisons

Effecty: The $95 semaglutide offer is a discounted first month.

AgelessRx: The $139 starting figure belongs to a four-month plan.

Brightmeds: Compare the three-month pack with the renewing monthly plan.

These September 20 field notes add research options, not new ranking positions. Compare the exact offer and clinician access before choosing a service.

More program types to compare

Curex: The starting price needs a supply period and formulation.

Lemonaid Health: The promotional banner and detailed price table need reconciliation.

LumiMeds: The payment term matters more than the lowest monthly equivalent.

These September 20 field notes add research options, not new ranking positions. Compare the exact offer and clinician access before choosing a service.

Further clinic and online comparisons

Nu Image Medical: The $99 semaglutide headline refers to a twelve-month supply.

Factor Health MD: The annual headline and early-cancellation policy need to be read together.

Bioverse: Confirm the purchase term behind the advertised starting rate.

These September 20 field notes add research options, not new ranking positions. Compare the exact offer and clinician access before choosing a service.

More payment terms and care models to compare

10rx: Quarterly pricing needs a complete three-month quote.

Alternate Health Club: Direct provider conversations carry a separate published fee.

Belle Health: The tirzepatide starter discount has a specific eligibility limit.

These September 20 field notes add research options, not new ranking positions. Compare the exact offer and clinician access before choosing a service.

Sources & reading notes

Public materials checked September 19, 2026. Provider pages establish advertised terms, not independent proof of outcomes or service quality. Clinical information is general and is not personal medical advice. No clinician review of this article is claimed.

  1. FDA: concerns with unapproved GLP-1 drugs
  2. FDA: GLP-1 supply and compounding policies
  3. CoreAge Rx: semaglutide product page
  4. CoreAge Rx: tirzepatide product page
  5. Mochi Health: current pricing and care FAQs
  6. Fridays: compounded medication plan prices
  7. Eden: current product and membership disclosures
  8. Henry Meds: program terms and medication quantities
  9. RemedyMeds: compounded tirzepatide offer
  10. Ro: weight loss program pricing
  11. Hims & Hers: March 2026 weight loss business update

How we research · How commercial placement works